Literature DB >> 8268135

The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus.

A Waisman1, S Mendlovic, P J Ruiz, H Zinger, A Meshorer, E Mozes.   

Abstract

Experimental systemic lupus erythematosus (SLE) has been induced in mice by immunization with either a human anti-DNA mAb bearing a common idiotype (Id) designated 16/6 Id (antibody 1, Ab1) or with a murine anti-16/6 Id mAb (Ab2). In the present study a murine mAb (5G12-4, Ab3) that bears the 16/6 Id and binds to DNA was produced and was found to bind rabbit anti-16/6 Id sera and murine anti-16/6 Id mAb similarly to the human mAb 16/6 Id (Ab1). Moreover, mAb 5G12-4 was shown to share T cell epitopes with the human 16/6 Id mAb, since lymph node cells of mice immunized with the mAb 5G12-4 proliferated significantly to the human 16/6 mAb and vice versa. Following immunization of mice with the murine mAb bearing the 16/6 Id, antibodies to dsDNA, ssDNA, 16/6 Id, anti-16/6 Id, and to HeLa nuclear extract proteins were detected, similarly to those observed previously upon immunization with Ab1 or Ab2. Six months following the immunization, the mice exhibited leukopenia, increased erythrocyte sedimentation rates, and proteinuria. Examination of the kidneys of the mice disclosed immune complex deposits, thickening of the Bowman's capsule and glomerular necrosis. These results show the importance of the 16/6 Id network in the induction and progression of SLE in mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268135     DOI: 10.1093/intimm/5.10.1293

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

1.  Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.

Authors:  M Dayan; R Segal; Z Sthoeger; A Waisman; N Brosh; O Elkayam; E Eilat; M Fridkin; E Mozes
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

2.  Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody.

Authors:  E Eilat; H Zinger; A Nyska; E Mozes
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

3.  Idiotype usage by polyclonally activated B cells in experimental autoimmunity and infection.

Authors:  M Sutmuller; J J Baelde; M P Madaio; J A Bruijn; E De Heer
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus.

Authors:  E Eilat; M Dayan; H Zinger; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta.

Authors:  Amir Sharabi; Heidy Zinger; Maya Zborowsky; Zev M Sthoeger; Edna Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

6.  Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients.

Authors:  N Mauermann; Z Sthoeger; H Zinger; E Mozes
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

7.  The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models.

Authors:  Uri Sela; Amir Sharabi; Molly Dayan; Rami Hershkoviz; Edna Mozes
Journal:  Immunology       Date:  2008-11-24       Impact factor: 7.397

8.  Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?

Authors:  D S Tawfik; R Chap; B S Green; M Sela; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

9.  A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide.

Authors:  Amir Sharabi; Molly Dayan; Heidy Zinger; Edna Mozes
Journal:  J Clin Immunol       Date:  2009-09-16       Impact factor: 8.317

10.  Neonatal lupus erythematosus with cardiac involvement in offspring of mothers with experimental systemic lupus erythematosus.

Authors:  F Kalush; E Rimon; A Keller; E Mozes
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.